山东大学学报 (医学版) ›› 2018, Vol. 56 ›› Issue (10): 86-92.doi: 10.6040/j.issn.1671-7554.0.2017.925
• • 上一篇
公孙鑫,辛钟伟,史墨,秦启明,姜斌,宋学敏,刘相燕
GONGSUN Xin, XIN Zhongwei, SHI Mo, QIN Qiming, JIANG Bin, SONG Xuemin, LIU Xiangyan
摘要: 目的 探讨黏蛋白1 C亚基(MUC1-C)在食管鳞癌中的表达定位及在肿瘤细胞恶性生物学行为中的作用。 方法 Western blotting检测MUC1-C在食管鳞癌组织及正常组织细胞核内的表达;运用穿膜肽Go-201抑制MUC1-C入核后,集落实验及CCK-8实验检测食管鳞癌细胞的活性、生长和增殖能力;划痕实验及Transwell小室实验检测食管鳞癌细胞迁移及侵袭能力;流式细胞术检测食管鳞癌细胞凋亡率。 结果 MUC1-C在食管鳞癌组织细胞核内的表达高于正常组织,抑制MUC1-C入核后食管鳞癌细胞活性、生长、增殖、迁移、侵袭能力均降低,凋亡率增高。 结论 MUC1-C通过入核发挥作用,能诱导和促进食管鳞癌细胞的恶性生长、增殖、迁移、侵袭,抑制肿瘤细胞的凋亡。
中图分类号:
[1] Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12):2893-2917. [2] Kufe DW. Mucins in cancer: function, prognosis and therapy[J]. Nat Rev Cancer, 2009, 9(12):874-885. [3] Alam M, Ahmad R, Rajabi H, et al. MUC1-C oncoprotein activates ERK→C/EBPβ signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells[J]. J Biol Chem, 2013, 288(43):30892-30903. [4] Martin JC, Herbert BS, Hocevar BA. Disabled-2 downregulation promotes epithelial-to-mesenchymal transition[J]. Bit J Cancer, 2010, 103(11):1716-1723. [5] Leng Y, Cao C, Ren J, et al. Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62[J]. J Biol Chem, 2007, 282(27):19321-19330. [6] Takahashi H, Jin C, Rajabi H, et al. MUC1-C activates the TAK1 inflammatory pathway in colon cancer[J]. Oncogene, 2015, 34(40):5187-5197. [7] Huang HL, Wu HY, Chu PC, et al. Role of integrin-linked kinase in regulating the protein stability of the MUC1-C oncoprotein in pancreatic cancer cells[J]. Oncogenesis, 2017, 6(7):e359. doi:10.1038/oncsis.2017.61. [8] Bouillez A, Rajabi H, Pitroda S, et al. Inhibition of MUC1-C suppresses MYC expression and attenuates malignant growth in KRAS mutant lung adenocarcinomas[J]. Cancer Res, 2016, 76(6):1538-1548. [9] Tagde A, Rajabi H, Bouillez A, et al. MUC1-C drives MYC in multiple myeloma[J]. Blood, 2016, 127(21):2587-2597. [10] Kharbanda A, Rajabi H, Jin C, et al. MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells[J]. Oncotarget, 2014, 5(19):8893-8905. [11] Rajabi H, Tagde A, Alam M, et al. DNA methylation by DNMT1 and DNMT3b methyltransferases is driven by the MUC1-C oncoprotein in human carcinoma cells[J]. Oncogene, 2016, 35(50):6439-6445. [12] Siddique HR, Saleem M. Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences[J]. Stem Cells, 2012, 30(3):372-378. [13] Hiraki M, Maeda T, Bouillez A, et al. MUC1-C activates BMI1 in human cancer cells[J]. Oncogene, 2017, 36(20):2791-2801. [14] David JM, Hamilton DH, Claudia P. MUC1 upregulation promotes immune resistance in tumor cells undergoing brachyury-mediated epithelial-mesenchymal transition[J]. Oncoimmunology, 2016, 5(4):e1117738. doi:10.1080/2162402X.2015.1117738. [15] Bouillez A, Rajabi H, Jin C, et al. MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer[J]. Oncogene, 2017, 36(28):4037-4046. [16] Raina D, Agarwal P, Lee J, et al. Characterization of the MUC1-C cytoplasmic domain as a cancertarget[J]. PLoS One, 2015, 10(8):e0135156. doi:10.1371/journal.pone.0135156.eCollection 2015. [17] Sun ZG, Wang Z, Liu XY. Mucin 1 and vascular endothelial growth factor C expression correlates with lymph node metastatic recurrence in patients with N0 esophageal cancer after Ivor-Lewis esophagectomy[J]. World J Surg, 2011, 35(1):70-77. [18] Li SH, Wang Z, Liu XY, et al. Lymph node micrometastasis: a predictor of early tumor relapse after complete resection of histologically node-negative esophageal cancer[J]. Surg Today, 2007, 37(12):1047-1052. [19] 王衍泽, 管向臣, 史墨, 等. RNA干扰沉默黏蛋白1基因表达对食管癌细胞株Eca109顺铂耐药性的影响[J]. 中华实验外科杂志, 2017, 34(9):1476-1478. WANG Yanze, GUANXiangchen, SHI Mo, et al. Effects of silencing mucin 1 with RNA interference on drug resistance of esophageal squamous cell carcinoma Eca109 to cisplatin[J]. Chin J Exp Surg, 2017, 34(9):1476-1478. |
[1] | 张士宝 刘庆勇 阮喜云 陈杰 张建军 李宗武 杨广笑 王全颖. NT4-SAC-HA2-TAT融合基因表达载体的构建及鉴定[J]. 山东大学学报(医学版), 2209, 47(6): 15-19. |
[2] | 鹿向东 杨伟 徐广明 曲元明. 脑膜瘤中PPAR-γ的表达及曲格列酮对脑膜瘤培养细胞生长的影响[J]. 山东大学学报(医学版), 2209, 47(6): 65-. |
[3] | 赵舸,邹存华,宋冬冬,赵淑萍. 丹参酮IIA对子宫内膜癌细胞增殖与凋亡的影响[J]. 山东大学学报 (医学版), 2022, 60(9): 53-58. |
[4] | 高中霞,张铭,樊明德,谭晨阳,王梦迪,王超,樊跃飞,丁守銮,王成伟. 伽玛刀治疗81例肺癌脑转移瘤的疗效及预后因素[J]. 山东大学学报 (医学版), 2022, 60(8): 44-49. |
[5] | 刘敏,张玉超,马小莉,刘昕宇,孙露,左丹,刘元涛. 孤核受体NR4A1在H2O2诱导小鼠肾脏足细胞损伤中的作用[J]. 山东大学学报 (医学版), 2022, 60(5): 16-21. |
[6] | 申晓畅,孙一卿,颜磊,赵兴波. 芳基烃受体核转位因子样蛋白2在子宫内膜癌中的表达[J]. 山东大学学报 (医学版), 2022, 60(5): 74-80. |
[7] | 赵婷婷,齐亚娜,张颖,袁冰,韩明勇. 小鼠乳腺癌诱导转移前肺组织微环境的改变[J]. 山东大学学报 (医学版), 2022, 60(4): 24-29. |
[8] | 钟黎黎,盛莹,郭江虹,阳双健,何宜静. LncRNA-UCA1通过靶向调控miR-182-5p对滋养细胞侵袭与转移的影响[J]. 山东大学学报 (医学版), 2022, 60(3): 76-82. |
[9] | 李卉,姜朝阳,刘岩,张曼. 组蛋白去乙酰化酶SIRT1调控氧化低密度脂蛋白诱导巨噬细胞凋亡的表达[J]. 山东大学学报 (医学版), 2022, 60(1): 6-12. |
[10] | 褚晏,刘端瑞,朱文帅,樊荣,马晓丽,汪运山,郏雁飞. DNA甲基化转移酶在胃癌中的表达及其临床意义[J]. 山东大学学报 (医学版), 2021, 59(7): 1-9. |
[11] | 卢游,且迪,伍晋辉,杨凡. 干预Sonic Hedgehog信号通路对宫内发育迟缓新生大鼠学习记忆能力的影响[J]. 山东大学学报 (医学版), 2021, 59(5): 82-89. |
[12] | 南莉,杨凯转,张一帆. 室内照明白色发光二极管对大鼠视网膜的影响[J]. 山东大学学报 (医学版), 2021, 59(4): 56-62. |
[13] | 柴佳威,朱坤兵,张华伟,崔凤云,王甜甜,田兴松. 1例肝细胞肝癌甲状腺转移罕见病例报道与文献回顾[J]. 山东大学学报 (医学版), 2021, 59(3): 120-124. |
[14] | 刘淑丹,张飞燕,郭松林,梁雪云,陈冬梅. 氧化苦参碱改善缺氧缺血引起的HaCaT细胞氧化应激损伤[J]. 山东大学学报 (医学版), 2021, 59(3): 26-34. |
[15] | 高金梅,张向莲,刘铁菊. 血浆D-二聚体与109例膀胱癌中发生31例转移的关联性分析[J]. 山东大学学报 (医学版), 2021, 59(3): 98-102. |
|